Systemic lupus erythematosus (SLE)
Cristina Arriens, MD, MS
Oklahoma Medical Research Foundation
Oklahoma City, OK, United States
Disclosure(s): AstraZeneca: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Aurinia: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing)
Skin rashes are common concerns for patients with lupus, and are complicated by mimics and a variety of clinical phenotypes requiring a multidisciplinary approach to diagnosis and management. Collaboration between rheumatology and dermatology is key to the correct diagnosis and optimal management of cutaneous lupus, including the role of biopsies. This session will update attendees on the most recent therapeutic developments.
Speaker: Victoria Werth, MD – University of Pennsylvania
Speaker: Alisa Femia
Speaker: J. Michelle Kahlenberg, MD, PhD – University of Michigan
